The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages

被引:123
|
作者
Martin, Darren P. [1 ]
Weaver, Steven [2 ]
Tegally, Houriiyah [3 ]
San, James Emmanuel [3 ]
Shank, Stephen D. [2 ]
Wilkinson, Eduan [3 ]
Lucaci, Alexander G. [2 ]
Giandhari, Jennifer [3 ]
Naidoo, Sureshnee [3 ]
Pillay, Yeshnee [3 ]
Singh, Lavanya [3 ]
Lessells, Richard J. [3 ]
Gupta, Ravindra K. [4 ,5 ]
Wertheim, Joel O. [6 ]
Nekturenko, Anton [7 ]
Murrell, Ben [8 ]
Harkins, Gordon W. [9 ]
Lemey, Philippe [10 ]
MacLean, Oscar A. [11 ]
Robertson, David L. [11 ]
de Oliveira, Tulio [3 ,12 ]
Pond, Sergei L. Kosakovsky [2 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Integrat Biomed Sci, Div Computat Biol, ZA-7701 Cape Town, South Africa
[2] Temple Univ, Dept Biol, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA
[3] Univ KwaZulu Natal, Sch Lab Med & Med Sci, KwaZulu Natal Res Innovat & Sequencing Platform, ZA-4001 Durban, South Africa
[4] Univ Cambridge, Clin Microbiol, Cambridge CB2 1TN, England
[5] Africa Hlth Res Inst, ZA-4013 Kwa Zulu, South Africa
[6] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[7] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA
[8] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-14183 Stockholm, Sweden
[9] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Capac Dev Unit, ZA-7635 Bellville, South Africa
[10] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium
[11] Univ Glasgow, Ctr Virus Res, MRC, Glasgow 12 8QQ, Lanark, Scotland
[12] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会; 欧洲研究理事会; 美国国家科学基金会;
关键词
RECEPTOR-BINDING DOMAIN; MUTATIONS;
D O I
10.1016/j.cell.2021.09.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The independent emergence date in 2020 of the B.1.1.7, B.1.351, and P.1 lineages of SARS-CoV-2 prompted renewed concerns about the evolutionary capacity of this virus to overcome public health interventions and rising population immunity. Here, by examining patterns of synonymous and non-synonymous mutations that have accumulated in SARS-CoV-2 genomes since the pandemic began, we find that the emergence of these three "501Y lineages" coincided with a major global shift in the selective forces acting on various SARS-CoV-2 genes. Following their emergence, the adaptive evolution of 501Y lineage viruses has involved repeated selectively favored convergent mutations at 35 genome sites, mutations we refer to as the 501Y meta-signature. The ongoing convergence of viruses in many other lineages on this meta-signature suggests that it includes multiple mutation combinations capable of promoting the persistence of diverse SARS-CoV-2 lineages in the face of mounting host immune recognition.
引用
收藏
页码:5189 / +
页数:19
相关论文
共 50 条
  • [21] The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
    Lu, Lu
    Chu, Allen Wing-Ho
    Zhang, Ricky Ruiqi
    Chan, Wan-Mui
    Ip, Jonathan Daniel
    Tsoi, Hoi-Wah
    Chen, Lin-lei
    Cai, Jian-Piao
    Lung, David Christopher
    Tam, Anthony Raymond
    Yau, Yat-Sun
    Kwan, Mike Yat-Wah
    To, Wing-Kin
    Tsang, Owen Tak-Yin
    Lee, Larry Lap-Yip
    Yi, Haisu
    Ip, Tak-Chuen
    Poon, Rosana Wing-Shan
    Siu, Gilman Kit-Hang
    Mok, Bobo Wing-Yee
    Cheng, Vincent Chi-Chung
    Chan, Kwok Hung
    Yuen, Kwok-Yung
    Hung, Ivan Fan-Ngai
    Kai-Wang To, Kelvin
    EBIOMEDICINE, 2021, 71
  • [22] In silico analysis of SARS-CoV-2 spike protein N501Y and N501T mutation effects on human ACE2 binding
    Cubuk, Hasan
    Ozbil, Mehmet
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 116
  • [23] Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
    Colson, Philippe
    Delerce, Jeremy
    Burel, Emilie
    Dahan, Jordan
    Jouffret, Agnes
    Fenollar, Florence
    Yahi, Nouara
    Fantini, Jacques
    La Scola, Bernard
    Raoult, Didier
    ARCHIVES OF VIROLOGY, 2022, 167 (04) : 1185 - 1190
  • [24] N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding
    Niu, Zubiao
    Zhang, Zhengrong
    Gao, Xiaoyan
    Du, Peng
    Lu, Jingjing
    Yan, Bohua
    Wang, Chenxi
    Zheng, You
    Huang, Hongyan
    Sun, Qiang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [25] SARS-CoV-2 spike evolutionary behaviors; simulation of N501Y mutation outcomes in terms of immunogenicity and structural characteristic
    Rostami, Neda
    Choupani, Edris
    Hernandez, Yaeren
    Arab, Seyed S.
    Jazayeri, Seyed M.
    Gomari, Mohammad M.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2022, 123 (02) : 417 - 430
  • [26] Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein
    Philippe Colson
    Jérémy Delerce
    Emilie Burel
    Jordan Dahan
    Agnès Jouffret
    Florence Fenollar
    Nouara Yahi
    Jacques Fantini
    Bernard La Scola
    Didier Raoult
    Archives of Virology, 2022, 167 : 1185 - 1190
  • [27] Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
    Leung, Kathy
    Shum, Marcus H. H.
    Leung, Gabriel M.
    Lam, Tommy T. Y.
    Wu, Joseph T.
    EUROSURVEILLANCE, 2021, 26 (01) : 15 - 21
  • [28] Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2
    Zhao, Shi
    Lou, Jingzhi
    Chong, Marc K. C.
    Cao, Lirong
    Zheng, Hong
    Chen, Zigui
    Chan, Renee W. Y.
    Zee, Benny C. Y.
    Chan, Paul K. S.
    Wang, Maggie H.
    VIRUSES-BASEL, 2021, 13 (04):
  • [29] N501Y mutation imparts cross-species transmission of SARS-CoV-2 to mice by enhancing receptor binding
    Zubiao Niu
    Zhengrong Zhang
    Xiaoyan Gao
    Peng Du
    Jingjing Lu
    Bohua Yan
    Chenxi Wang
    You Zheng
    Hongyan Huang
    Qiang Sun
    Signal Transduction and Targeted Therapy, 6
  • [30] The Emergence and Evolution of SARS-CoV-2
    Holmes, Edward C.
    ANNUAL REVIEW OF VIROLOGY, 2024, 11 : 21 - 42